FMA Advisory’s Allergan plc AGN Stock Holding History

FMA Advisory’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-2,755	Closed	-$397K	–	167
2013 Q3	$397K	Buy	2,755 +157	+6%	+$20.9K	0.16%	133
2013 Q2	$328K	Buy	+2,598	New	+$294K	0.14%	140

Other funds holding AGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FMA Advisory's AGN Position: Q4 2013 in Review

FMA Advisory sold out of Allergan plc (AGN) in Q4 2013, closing a stake of 2,755 shares — an estimated $397K sold.

FMA Advisory first reported a position in AGN in Q2 2013 and held it in 2 quarters. The position peaked at $397K in Q3 2013. 552 funds tracked by Wall St. Rank hold AGN as of Q4 2013.

FMA Advisory reported no remaining Allergan plc position as of Q4 2013 after selling out during the quarter.
FMA Advisory sold 2,755 Allergan plc shares in Q4 2013, an estimated $397K.
FMA Advisory first reported a position in Allergan plc in Q2 2013 and held it in 2 quarters.
FMA Advisory's Allergan plc position peaked at $397K in Q3 2013.
552 funds tracked by Wall St. Rank held Allergan plc as of Q4 2013.

Based on FMA Advisory's 13F filing for Q4 2013, filed 10 Feb 2014.